Kestra Medical Technologies, Ltd. (KMTS) Reports Q2 Loss of $2.21

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q2 EPS of ($2.21). Revenue for the quarter came in at $17.2 million.

For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.

You May Also Be Interested In

• JPMorgan Downgrades Cyient DLM Ltd (CYIENTDL:IN) to Underweight
• Spruce Biosciences (SPRB) Reiterated at Market Outperform by Citizens on TA-ERT Therapy Lead
• Espey Manufacturing (ESP) Tops Q4 EPS by 24c